Table 1.
Demographic characteristics of the study participants stratified by HPV16/HPV18 positivity.
| Total | HPV16/HPV18-negative | HPV16/HPV18-positive | p-value | |
|---|---|---|---|---|
| N = 1,226 | N = 1,132 | N = 94 | ||
| Age (mean & IQR) | 23 (21–24) | 23 (21–24) | 23 (21–24) | 0.26 |
| Region of residence | 0.55 | |||
| Berlin | 94 (7.7%) | 85 (7.5%) | 9 (9.6%) | |
| East—rural | 243 (19.8%) | 228 (20.1%) | 15 (16.0%) | |
| West—rural | 290 (23.7%) | 272 (24.0%) | 18 (19.1%) | |
| East—urban | 349 (28.5%) | 318 (28.1%) | 31 (33.0%) | |
| West—urban | 250 (20.4%) | 229 (20.2%) | 21 (22.3%) | |
| German citizenship | 0.62 | |||
| No | 32 (2.6%) | 29 (2.6%) | 3 (3.2%) | |
| Yes | 1,170 (95.4%) | 1,082 (95.6%) | 88 (93.6%) | |
| Missing | 24 (2.0%) | 21 (1.9%) | 3 (3.2%) | |
| Education | 0.074 | |||
| Low education | 29 (2.4%) | 27 (2.4%) | 2 (2.1%) | |
| Medium education | 202 (16.5%) | 179 (15.8%) | 23 (24.5%) | |
| High education | 967 (78.9%) | 902 (79.7%) | 65 (69.1%) | |
| Missing | 28 (2.3%) | 24 (2.1%) | 4 (4.3%) | |
| Income | 0.070 | |||
| <1,000 EUR | 413 (33.7%) | 374 (33.0%) | 39 (41.5%) | |
| 1,000–2,00 EUR | 346 (28.2%) | 314 (27.7%) | 32 (34.0%) | |
| 2,000–3,000 EUR | 231 (18.8%) | 220 (19.4%) | 11 (11.7%) | |
| >3,000 EUR | 200 (16.3%) | 191 (16.9%) | 9 (9.6%) | |
| Missing | 36 (2.9%) | 33 (2.9%) | 3 (3.2%) | |
| Smoking | 0.30 | |||
| No | 854 (69.7%) | 794 (70.1%) | 60 (63.8%) | |
| Yes | 245 (20.0%) | 220 (19.4%) | 25 (26.6%) | |
| Not anymore | 101 (8.2%) | 95 (8.4%) | 6 (6.4%) | |
| Not specified | 26 (2.1%) | 23 (2.0%) | 3 (3.2%) | |
| Immunodeficiency | 0.17 | |||
| No | 1,160 (94.6%) | 1,075 (95.0%) | 85 (90.4%) | |
| Yes | 30 (2.4%) | 26 (2.3%) | 4 (4.3%) | |
| Missing | 36 (2.9%) | 31 (2.7%) | 5 (5.3%) | |
| Cervical cancer screening | 0.71 | |||
| Never | 420 (34.3%) | 392 (34.6%) | 28 (29.8%) | |
| Yes, once | 200 (16.3%) | 182 (16.1%) | 18 (19.1%) | |
| Yes, regularly | 411 (33.5%) | 381 (33.7%) | 30 (31.9%) | |
| I don’t know | 170 (13.9%) | 155 (13.7%) | 15 (16.0%) | |
| Missing | 25 (2.0%) | 22 (1.9%) | 3 (3.2%) | |
| Cervical lesions | <0.001 | |||
| No | 1,097 (91.3%) | 1,022 (92.0%) | 75 (82.4%) | |
| Yes | 55 (4.6%) | 42 (3.8%) | 13 (14.3%) | |
| I don’t know | 46 (3.8%) | 43 (3.9%) | 3 (3.3%) | |
| Missing | 4 (0.3%) | 4 (0.4%) | 0 (0.0%) | |
| Treatment genital warts | 0.54 | |||
| No | 1,179 (96.2%) | 1,090 (96.3%) | 89 (94.7%) | |
| Yes | 15 (1.2%) | 13 (1.1%) | 2 (2.1%) | |
| I don’t know | 8 (0.7%) | 8 (0.7%) | 0 (0.0%) | |
| Not specified | 24 (2.0%) | 21 (1.9%) | 3 (3.2%) | |
| Missing | 1,179 (96.2%) | 1,090 (96.3%) | 89 (94.7%) |
IQR, interquartile range. Statistically significant p-values in bold.